Similar Search Results

Product patents and access to innovative medicines in a post-trips-era

Watal, Jayashree; Dai, Rong - 2019

) How does the introduction of product patents in pharmaceuticals affect the likelihood of pharmaceutical firms to launch …This WTO working paper studies availability and affordability of new and innovative pharmaceuticals in a post-TRIPS era …) - to provide pharmaceutical product patents with a 20-year protection term. Developing country members, other than LDCs …

Persistent link: https://www.econbiz.de/10011996454

Novelty and scope of process innovation: The role of related and unrelated manufacturing experience

Lugovoi, Ivan; Andritsos, Dimitrios A.; Senot, Claire - In: Production and Operations Management 31 (2022) 10, pp. 3877-3895

The accumulation of experience that occurs with production is likely to impact an organization's ability to develop manufacturing process innovations. However, how different types of manufacturing experience relate to the characteristics of an organization's process innovation output is an open...

Persistent link: https://www.econbiz.de/10013465303

R&D Productivity and Firm Size in Semiconductors and Pharmaceuticals: Evidence from Citation Yields

Dindaroğlu, Burak - 2011

important and R&D-intensive industries: Semiconductors and Pharmaceuticals. I employ two measures of a firm's R&D performance …&D expenditures. The former is a measure of the average quality of a firm's patents, and the latter is a measure of total R&D output … obtained per dollar of investments. I find that the average quality of patents (citations received per patent) falls with firm …

Persistent link: https://www.econbiz.de/10011807210

Economics at the FTC : pharmaceutical patent dispute settlements and behavioral economics

Salinger, Michael A.; Ippolito, Pauline M.; Schrag, Joel L. - In: Review of industrial organization : RIO 31 (2007) 2, pp. 85-105

Persistent link: https://www.econbiz.de/10003718355

The pharmaceutical market in the people's Republic of China in transition : current situation and development trends

Chou, Yu-Wen - 2008

Persistent link: https://www.econbiz.de/10003756813

Competition in off-patent drug markets : issues, regulation and evidence

Kanavos, Panos; Costa-Font, Joan; Seeley, Elizabeth - In: Economic policy : a European forum 55 (2008), pp. 499-544

Persistent link: https://www.econbiz.de/10003741151

Pharmaceutical patents : incentives for R&D or marketing?

Brekke, Kurt R. (contributor); Straume, Odd Rune (contributor) - 2008

We analyse how a patent-holding pharmaceutical firm may strategically use advertising of existing drugs to affect R&D investments in new (differentiated) drugs, and thereby affect the probability distribution of future market structures in the industry. Within a fairly general model framework,...

Persistent link: https://www.econbiz.de/10003771873

Special issue: Trips and beyond : pharmaceutical patents and test data protection

Correa, Carlos María (contributor) - 2006

Persistent link: https://www.econbiz.de/10003771903

Assessind the role of IPRs to foster R&D : the case of vaccines and drugs for neglected diseases

Szogs, Astrid (contributor) - In: International journal of economic development : IJED 6 (2004) 4, pp. 89-111

Persistent link: https://www.econbiz.de/10003282217

Price controls, patents, and cross-border internet pharmacies : risks to Canada's drug supply and international trading relations

Skinner, Brett J. - 2006

Persistent link: https://www.econbiz.de/10003305729